What's Happening?
KORU Medical Systems, Inc., a medical technology company specializing in large volume subcutaneous infusion solutions, announced a 27% increase in net revenues for the third quarter of 2025, totaling $10.4
million. This growth is attributed to a strong performance in both domestic and international markets, with international core revenues seeing a significant rise of 229.6%. The company also reported a gross profit increase of 21% to $6.3 million, despite a net loss of $0.8 million, which marks a 51% improvement over the previous year. KORU Medical has raised its full-year revenue guidance to $40.5 - $41.0 million, indicating a year-over-year growth of 20% - 22%. The company continues to focus on expanding its international footprint and forming new pharmaceutical collaborations.
Why It's Important?
The revenue growth and raised guidance reflect KORU Medical's successful strategic initiatives and market expansion efforts. The company's ability to increase its international market share and form new collaborations positions it well for future growth. This development is significant for stakeholders in the medical technology industry, as it highlights the potential for increased innovation and market penetration in subcutaneous infusion solutions. The improved financial performance also suggests a positive outlook for investors, with expectations of continued revenue growth and cash flow generation.
What's Next?
KORU Medical plans to continue its focus on accelerating revenue growth and advancing its innovation pipeline. The company aims to expand its international presence and form additional pharmaceutical collaborations to reach broader patient populations. The upcoming conference call and webcast scheduled for November 12, 2025, will provide further insights into the company's strategic plans and financial outlook. Stakeholders can expect updates on the company's efforts to improve gross margins and cash flow in the fourth quarter of 2025.
Beyond the Headlines
The company's focus on patient-centric solutions and international expansion may lead to long-term shifts in healthcare delivery, particularly in the subcutaneous infusion market. KORU Medical's collaborations with pharmaceutical companies could drive advancements in drug delivery systems, potentially improving patient outcomes and quality of life. The company's strategic growth initiatives may also influence competitive dynamics within the medical technology sector.
